News in the Life Sciences Industry

Portfolio Company, Astral Health and Miller & Miller form a New Joint Venture to Open Up the UK Market

BASEL, Switzerland, May 17, 2019 /PRNewswire/ -- Read more ››

STOCKHOLM, May 15, 2019 /PRNewswire/ -- Cantargia AB today announces that the abstract of the upcoming oral presentation of CAN04 phase I clinical data at the 2019 ASCO Annual Meeting is published on the conference website. The abstract reports available data on the 22 patients in the phase... Read more ››

MARBURG, Germany, May 16, 2019 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that the company has... Read more ››

DARMSTADT, Germany, May 16 2019 /PRNewswire/ --

COPENHAGEN, Denmark, May 15, 2019 /PRNewswire/ -- IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune modulating anti-cancer therapies based on its proprietary T-win® technology, announced the initiation of the Phase 2 portion of a global, open-label, randomized clinical... Read more ››

A new Board of Directors has been appointed

SHANGHAI and HONG KONG, May 15, 2019 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("China Ping An", "Ping An", the "Group" or the "Company"; stock codes: HKEX 2318 and SSE 601318) is pleased to announce that its technology arm, Ping An Technology, has completed a prospective... Read more ››

DARMSTADT, Germany and NEW YORK, May 15, 2019 /PRNewswire/ --

SINGAPORE, May 13, 2019 /PRNewswire/ -- Mundipharma has extended its portfolio of nutraceuticals by launching Maxvida(()(TM)) - a balanced nutritional supplement with 32 key nutrients - in Vietnam.

Not intended for U.S. media

HONG KONG, May 10, 2019 /PRNewswire/ -- Ally Bridge Group ("ABG"), a leading global life science investment group, announced today that it led an over-subscribed $65 million financing of Pulmonx Corporation, a global leader in diagnostic and therapeutic pulmonary device technologies with its... Read more ››